Sinopep-Allsino Biopharmaceutical

Sinopep-Allsino Biopharmaceutical Co Ltd. (Stock Code: 688076) is a leading, company driven by innovation, specialized in the production and development of peptides, oligonucleotides, and small molecules. Leveraging years of expertise, Sinopep supplies products for use in research, clinical development, and commercial application to pharmaceutical and biotech firms globally. It also provides CDMO/CRO services with 3 RND centers and 2 manufacturing sites (EDQM&FDA approved sites). The majority of its drug substances have obtained approval in the US, EU, UK & CN market.

Products & Services

Fulvestrant

Lanreotide Acetate

Liraglutide

Country

People's Republic of China

Show site details

Audit report available

Sinopep - Allsino Biopharmaceutical Co. Ltd

Country

People's Republic of China

City

Jiangsu

Semaglutide

Tirzepatide

Sites